Details
Description
Hepatitis B Viral
DNA Quantitative/Qualitative Fluorescence Diagnostic Kit (proHBV, PCR-Fluorescence Probing)
In 2015, hepatitis B resulted in 887,000 deaths, mostly from complications (including cirrhosis and hepatocellular carcinoma). All patients with chronic HBV infection are at increased risk of progression
to cirrhosis and hepatocellular carcinoma (HCC). A sensitive polymerase chain reaction assay is recommended for virological response during therapy for patients with chronic HBV infections as to improve survival and quality of life by preventing disease progression.
Product Performance
- Methodology: Magnetic-bead technology
- Sample Type: Serum, Plasma
- Sample Input Volume: 200 µI
- Genotype Detection: HBV genotypes A-H
- Linear Range: 9
- Sensitivity: 20-2x I 0 IU/ml
- IOIU/ml
Features & Advantages
- Simplified DNA Extraction Steps
- Ultra Sensitivity of IO IU/ml
- Internal Control Monitor
- Full Automation Enabled
Application
- It can be used for accurate and high-sensitivity diagnosis of HBV infection as to raise awareness for timely treatment and transmission prevention.
- It can serve as the reliable basis to assess the stage of HBV infection and eligibility for treatment, as well as the clinical medication guidance to monitor viral load and disease progression for antiviral treatment.
- It can provide modern molecular laboratories with the most advanced combination of turn-around time and throughput with 48/96 samples (Natch CS I Natch S ) in 3.5 hours.
- It provides the patients with chronic HBV infections with an affordable, accessible and sustainable alternative to monitor virological response during therapy as to guide clinical medication.
